ArticleJournal of neurology2025

Long-term CSF responses in adult patients with spinal muscular atrophy type 2 or 3 on treatment with nusinersen.

Gina Cebulla et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.